@article{db3dc5a299a5472896984bde77112c80,
title = "Reply to: revisiting the role of serine metabolism in hepatic lipogenesis",
author = "Zhaoyue Zhang and Tara TeSlaa and Rabinowitz, {Joshua D.}",
note = "Funding Information: J.R. is a consultant and received research funding from Pfizer and is an adviser and stock owner in Colorado Research Partners, L.E.A.F. Pharmaceuticals, Rafael Pharmaceuticals, Barer Institute and its subsidiaries, Serien Therapeutics, Empress Therapeutics, and Agios Pharmaceuticals. J.R. is co-inventor of SHIN2 and related SHMT inhibitors, which have been patented by Princeton University. The remaining authors declare no competing interests. Funding Information: Z.Z., T.T. and J.R. wrote the manuscript. This work was funded by the Allen Foundation and by Ludwig Cancer Research.",
year = "2023",
month = may,
doi = "10.1038/s42255-023-00793-z",
language = "American English",
volume = "5",
pages = "762--764",
journal = "Nature Metabolism",
issn = "2522-5812",
publisher = "Springer Berlin",
number = "5",
}